Explore more Categories
Artificial Intelligence involves the science and engineering of developing intelligent machines
The manufacturing world is at a cusp of a new revolution that will redefine conventional business models
IoT will have a major impact on businesses and consumers in the future
The world is creating 2.5 exabytes of data daily
Our research seeks to connect-the-dots across multiple trends
Personal Robots are Set to Be a $19 Billion Market
Strategic Analysis of BREXIT and its Implications to Industries, Economies and Societies
iFrost is a digital platform for interactive and dynamic reporting of data.
The TOEs are a great source of information which gives corporates critical information on companies to action for their strategic investments either as an open source platform or to collaborate and to develop successful products
Investments in Single Use/Disposable Technologies to Capitalize on Growth Opportunities in High-value Low-volume Biologics
* Required Fields
Pay by invoice
The global pharmaceutical industry is evolving with the rising need for novel therapies in the changing disease landscape. As a result of rising prevalence of chronic infectious diseases as well as growing cancer incidence, market needs are shifting from traditional small molecules to large molecules. This study presents an overview of the global biologics Contract Development and Manufacturing Organization (CDMO) landscape with an emphasis on the key trends and growth opportunities across the global biologics outsourcing market. It also highlights the shifting focus and investments of pharma/biotech participants toward BioCDMOs for innovative biologics discovery, development, and manufacturing.With the changing market landscape, BioCDMOs are shifting toward providing value-added services by establishing themselves as a one-stop-shop for their pharma clients. These companies are adopting advanced manufacturing technologies such as single-use/disposable bioreactors, continuous, POD manufacturing, and so on with the integration of IT-based solutions implementing the Industrial Internet of Things (IIoT) by means of strategic collaborations and partnerships. Larger participants are resorting to Mergers and Acquisitions (M&As) in order to gain specific therapeutic and technical expertise from smaller, niche BioCDMOs. While the US and Europe are key markets, the outsourcing trend is slowly shifting toward APAC with several new entrants providing cost-effective drug development services.
The study aims at identifying some key growth opportunities such as biosimilars co-development, designer cell lines, bioanalytical development and services, and so on that are set to drive the market over the next 5 years. It provides revenue forecasts of the global BioCDMO market as well as a breakdown by type of cell culture (mammalian versus microbial) and service type (drug substance verus drug product). The study highlights some of the key market drivers and restraints that will affect the overall growth of the market. Additionally, it provides an insight into leading disruptive technology trends such as improvements in upstream and downstream technologies, advances in lyophilisation, and increased application of Process Analytical Technologies (PAT) that are shaping the future of the BioCDMO industry. The study also highlights some emerging business models such as expanding services of CMOs into early stage of drugs, emergence of virtual biotech, out-licensing, and risk sharing between pharma and CMOs that are disrupting traditional business models.
Key Issues Addressed
Growth Insights—Real World Evidence Analytics Solutions Market
Global Biologics Contract Development & Manufacturing Organization (CDMO) Market—Companies-to-Action
Global Biologics Market—Companies-to-Action
East African Pharmaceutical Market, Forecast to 2021
Global CRO Market, Forecast to 2021
Biomarkers Enabling Diabetes and Obesity Management
Global Pharmaceutical Contract Manufacturing Organization (CMO) Market
2016 Indonesia Transformational Health Insights
Pharmaceutical Market Access Strategy for Ethiopia
Vital Signs The Analyst's Perspective - April 2016 Issue
activated carbon market
diabetes care devices market
electric car market
residential energy storage market
Fill in the fields below to receive a sample report
Don't have an account? Create One!
Enter your Email Address here to receive a link to change password.
If you are an existing frost.com user, please register using the same email for seamless access
Already have an account? Login!
Use your Linkedin account to login or register within our store.You're just one click away.